Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population
7.367m
GDP (2003)
CHF438.438bn
Health expenditure (public, 2002)
Health expenditure as proportion of GDP
Size of pharmaceutical market (consumer prices)
Proportion of GDP spent on pharmaceuticals
Pharmaceuticals as a proportion of health spend
Pharmaceutical market growth rate (2003)
Local currency
Swiss Franc (CHF)
Summary: Switzerland
Switzerland operates the second most expensive healthcare in the world, one that is highly decentralised, well-developed and widely acknowledged (over 70% of the population) to be excellent. A large number of providers and insurers ensure stiff competition, enmeshed in a unique public-private participation combining public, subsidised private and fully private healthcare.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
10/10/2005
New insurance cards for treatments abroad to be issued
19/09/2005
Health insurance premiums to be raised in 2006, says Santésuisse
19/09/2005
Rx prices slash in 2006
Related Items